Molbio Diagnostics Ltd
Listed
NSE & BSE
Mainboard
Live Chart
| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 75.13x
|
5,812,862
|
— | ₹469.10 |
|
NII / HNI
|
Over 49.62x
|
1,743,860
|
— | ₹140.73 |
|
Retail
|
Over 12.65x
|
4,069,005
|
— | ₹328.37 |
|
Employees
|
Awaited |
20,520
|
— | ₹1.66 |
| Total | 1.95x | 20,519 |
100% | ₹1.66 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| QIB | 5,812,862 | ₹469.10 |
28,329.17%
|
| NII | 1,743,860 | ₹140.73 |
8,498.76%
|
| Retail | 4,069,005 | ₹328.37 |
19,830.43%
|
| Employee | 20,520 | ₹1.66 |
100.00%
|
| Total | 20,519 | ₹1.66 |
100.00%
|
| QIB | NII | Retail | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor | Total QIB | Below ₹10L | Above ₹10L | Total NII | |||
| Allocation (shares) | — | — | — | — | — | 1,743,860 | 4,069,005 | 5,812,865 |
| Allotment price (₹) | 807 | 807 | 807 | 807 | 807 | 807 | 807 | 807 |
| No. of applications | — | — | — | — | — | — | — | — |
| No. of shares applied | — | — | — | — | — | — | — | — |
| Amount collected (₹Cr) | — | — | — | — | — | — | ₹328.37 | ₹328.37 |
| Times subscribed | 75.13x | — | — | — | — | 49.62x | 12.65x | 1.95x |
| Shares allotted | — | — | — | — | — | 1,743,860 | 4,069,005 | 5,812,865 |
| No. of allottees | — | — | — | — | — | — | — | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 36 | ₹29,052 |
| Retail (Max — 13 Lots) | 13 | 234 | ₹188,838 |
| S-HNI (Min — 14 Lots) | 14 | 252 | ₹203,364 |
| B-HNI (Min — 69 Lots) | 69 | 1,242 | ₹1,002,294 |
Molbio Diagnostics Ltd is proposing an IPO on NSE & BSE under the Mainboard category. Total issue: 1,16,46,246 shares (agg. up to ₹940 Cr).
Opens 10 Aug 2026, closes 12 Aug 2026. Listing: 17 Aug 2026. Apply via ASBA or UPI.
| Particulars | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue from Operations | 1455.17 | 1027.94 | 840.66 |
| EBITDA | 328.24 | 256.64 | 185.09 |
| Profit After Tax (PAT) | 164.14 | 138.58 | 83.54 |
| Net Worth | 1144.68 | 952.95 | 807.94 |
| Total Assets | 2148.42 | 1461.56 | 1221.06 |
| Reserves & Surplus | 1148.84 | 990.84 | 845.48 |
| Borrowings | 412.64 | 123.16 | 174.58 |
| EBITDA Margin (%) | 22.56 | — | — |
| PAT Margin (%) | 11.28 | — | — |
Molbio Diagnostics Ltd IPO is subscribed 1.95 times by Aug 12, 2026. Retail: 12.65x. QIB: 75.13x. NII: 49.62x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 75.13x |
| Non Institutional (NII/HNI) | 49.62x |
| Retail Individual | 12.65x |
| Total Subscription | 1.95x |
The Molbio Diagnostics Ltd IPO retail category is subscribed 12.65 times as of 12 Aug 2026. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 10 Aug 2026 and closes 12 Aug 2026. Min investment: ₹14,526 (1 lot = 18 shares). UPI mandate: 5:00 PM on 12 Aug 2026.
The Molbio Diagnostics Ltd IPO subscribed 1.95x overall. QIB: 75.13x, NII: 49.62x, Retail: 12.65x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 18 Aug 2026. Refunds: on 19 Aug 2026.
The Molbio Diagnostics Ltd IPO listing date is 17 Aug 2026, Monday. Listed on: NSE & BSE. Issue price: ₹807. Estimated listing: ₹939. GMP: +₹132.
The Molbio Diagnostics Ltd IPO closes on 12 Aug 2026, Wednesday. UPI mandate: 5:00 PM on 12 Aug 2026. Allotment: 18 Aug 2026. Listing: 17 Aug 2026.